D

Day One Biopharmaceuticals Inc
NASDAQ:DAWN

Watchlist Manager
Day One Biopharmaceuticals Inc
NASDAQ:DAWN
Watchlist
Price: 12.79 USD 2.65% Market Closed
Market Cap: 1.3B USD
Have any thoughts about
Day One Biopharmaceuticals Inc?
Write Note

Wall Street
Price Targets

DAWN Price Targets Summary
Day One Biopharmaceuticals Inc

Wall Street analysts forecast DAWN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for DAWN is 37.74 USD with a low forecast of 28.28 USD and a high forecast of 50.4 USD.

Lowest
Price Target
28.28 USD
121% Upside
Average
Price Target
37.74 USD
195% Upside
Highest
Price Target
50.4 USD
294% Upside

DAWN Last Price Targets
Day One Biopharmaceuticals Inc

The latest public price target was made on Aug 1, 2024 by Alec Stranahan from Bank of America Securities , who expects DAWN stock to rise by 88% over the next 12 months. You can read more about this price target by viewing the article on TheFly.

Analyst Price Target Date Article
Alec Stranahan
Bank of America Securities
24 USD
Upside 88%
4 months ago
Aug 1, 2024
Day One Biopharmaceuticals upgraded to Buy from Underperform at BofA
TheFly
Andrew Maldonado
H.C. Wainwright
40 USD
Upside 213%
7 months ago
May 7, 2024
Day One Biopharmaceuticals (DAWN) PT Lowered to $40 at H.C. Wainwright
StreetInsider
Alec Stranahan
Bank of America Securities
Price Target 24 USD
Upside/Downside 88%
View Source
Andrew Maldonado
H.C. Wainwright
Price Target 40 USD
Upside/Downside 213%
View Source
Day One Biopharmaceuticals Inc Competitors:
Price Targets
MGX
Metagenomi Inc
363% Upside
XNCR
Xencor Inc
37% Upside
ELYM
Eliem Therapeutics Inc
230% Upside
ABBV
Abbvie Inc
20% Upside
BMRN
Biomarin Pharmaceutical Inc
51% Upside
1167
Jacobio Pharmaceuticals Group Co Ltd
204% Upside
IPSC
Century Therapeutics Inc
796% Upside
4891
TMS Co Ltd
254% Upside

Revenue
Forecast

Revenue Estimate
Day One Biopharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Day One Biopharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Net Income
Forecast

Net Income Estimate
Day One Biopharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-37%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is DAWN's stock price target?
Price Target
37.74 USD

According to Wall Street analysts, the average 1-year price target for DAWN is 37.74 USD with a low forecast of 28.28 USD and a high forecast of 50.4 USD.

Back to Top